Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RFX5 contributors: mct/npt - updated : 12-03-2019
HGNC name regulatory factor X, 5 (influences HLA class II expression)
HGNC id 9986
Corresponding disease
BLS2C Bare lymphocyte syndrome type II
Location 1q21.3      Physical location : 151.313.115 - 151.319.769
Synonym name regulatory factor X, 5
DNA
TYPE functioning gene
STRUCTURE 6.65 kb     11 Exon(s)
Genomic sequence alignment details
10 Kb 5' upstream gene genomic sequence study
regulatory sequence HSs hypertensive site
motif
MAPPING cloned Y linked N status confirmed
RNA
TRANSCRIPTS type messenger
text variants 1 and 2 encode the same protein
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
11 - 3618 - 616 - 2005 15655668
11 - 3611 - 616 - 2005 15655668
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveintestinesmall intestine   
Lymphoid/Immunelymph node   highly
 thymus   highly
Reproductivefemale systemuteruscervix highly
Respiratoryrespiratory tracttrachea  highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a specific DNA-binding domain, and RFX complex binds to X-box DNA, using this DNA binding domain
  • a dimerization domain
  • an oligomerization domain, promoting formation of a dimer of dimers of RFX5
  • an AT-hook motif
  • HOMOLOGY
    interspecies homolog to murine Rfx5
    Homologene
    FAMILY
  • RFX family
  • CATEGORY regulatory , transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    text
  • two RFX5 molecules and one RFXAP molecule assemble in the cytoplasm prior to nuclear localization, a process mediated by an N-terminal "dimerization domain" of RFX5 (RFX5(N)) and a C-terminal domain of RFXAP (RFXAP(C)
  • basic FUNCTION
  • transactivating DNA binding regulatory factor 5l, involved in MHC class II expression
  • important repressors of collagen gene transcription through a RFX binding site spanning the transcription start site
  • subunit of RFX complex involved in transcription regulation of MHCII molecules
  • role of a previously unidentified AT-hook motif of the MHCII regulatory factor RFX5, involved in regulating the transcription of the HLA-DQ, but not HLA-DR, MHCII isotype
  • essential and highly specific regulator of major histocompatibility class II (MHCII) gene expression in the immune system (pMID: 27840983)
  • CELLULAR PROCESS nucleotide, transcription
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    pathway RFX5/HDAC2 implicated in interferon-gamma-mediated repression
    a component
  • subunit of the multimeric phosphoprotein complex RFX, containing RFX5, RFXANK, RFXAP
  • dimerizes through two separate domains
  • forms the heterotrimeric RFX complex together with RFX5 and RFXAP, all are required for expression of MHCII genes
  • INTERACTION
    DNA binding to the MHC promoter box X
    RNA
    small molecule
    protein
  • HDAC2 cooperates with RFX5 to down-regulate collagen promoter activity
  • specifically interacts with histone deacetylase 2 (HDAC2) and the mammalian transcriptional repressor SIN3B
  • interaction between RFX5 and RFXAP promote folding of a poorly structured region of RFXAP, which is required for high affinity binding of RFXB to the RFX5/RFXAP complex
  • SIRT1 interacts with and deacetylates RFX5 (SIRT1 promotes cytoplasmic localization and proteasomal degradation of RFX5 and cripples promoter recruitment of RFX5)
  • NAMPT antagonized COL1A2 promoter repression by RFX5
  • RFX5 can strongly bind to the tripeptidyl peptidase 1 (TPP1) promoter region and then increase its transcriptional activity
  • cell & other
    REGULATION
    Other DNA binding of RFX5 is inhibited by domains flanking its DNA binding domain, and both RFXAP and RFXB are required to overcome the inhibition of both domains
    ASSOCIATED DISORDERS
    corresponding disease(s) BLS2C
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional germinal mutation      
    RFX5(L66A) point mutation prevents dimerization of the RFX complexes and may result a loss of MHCII gene expression
    tumoral     --over  
    in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS